Andrew J. Clear

Charterhouse Square
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications

Clinico-pathological diagnostic and prognostic biomarkers for duodenal adenocarcinoma from a UK retrospective cohort study.

Clinico-pathological diagnostic and prognostic biomarkers for duodenal adenocarcinoma from a UK retrospective cohort study.

Journal: Human pathology
Published: November 21, 2025

Clinico-pathological diagnostic and prognostic biomarkers for duodenal adenocarcinoma from a UK retrospective Cohort study.

Clinico-pathological diagnostic and prognostic biomarkers for duodenal adenocarcinoma from a UK retrospective Cohort study.

Journal: Human pathology
Published: November 21, 2025

Lamin B1 safeguards the B cell genome and shapes lymphoma outcome.

Lamin B1 safeguards the B cell genome and shapes lymphoma outcome.

Journal: HemaSphere
Published: November 07, 2025

Pan-cancer analysis reveals Rho kinase addiction as a vulnerability of de-differentiated cancer cells.

Pan-cancer analysis reveals Rho kinase addiction as a vulnerability of de-differentiated cancer cells.

Journal: iScience
Published: June 13, 2025

CREBBP histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphoma.

CREBBP histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphoma.

Journal: British journal of haematology
Published: April 22, 2024

PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma.

PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma.

Journal: The Journal of clinical investigation
Published: February 15, 2024

Autophagy is an upstream mediator of chromatin dynamics in normal and autoimmune germinal center B cells.

Autophagy is an upstream mediator of chromatin dynamics in normal and autoimmune germinal center B cells.

Journal: The Journal of clinical investigation
Published: December 27, 2023

Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment.

Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment.

Journal: HemaSphere
Published: October 27, 2022

Lack of reproducibility of histopathological features in MYC-rearranged large B cell lymphoma using digital whole slide images: a study from the Lunenburg lymphoma biomarker consortium.

Lack of reproducibility of histopathological features in MYC-rearranged large B cell lymphoma using digital whole slide images: a study from the Lunenburg lymphoma biomarker consortium.

Journal: Histopathology
Published: August 09, 2022

PDL1 shapes the classical Hodgkin lymphoma microenvironment without inducing T-cell exhaustion.

PDL1 shapes the classical Hodgkin lymphoma microenvironment without inducing T-cell exhaustion.

Journal: Haematologica
Published: July 11, 2022

Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV.

Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV.

Journal: Blood advances
Published: June 24, 2022

Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma.

Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma.

Journal: Blood advances
Published: March 18, 2022
Showing 1-12 of 51

Last Updated: 09/26/2026